Concepedia

Steffen Dickopf

SD

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2015

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

University of Basel

University of Cambridge

Cold Spring Harbor Laboratory

Steffen Dickopf is an author at Roche (Switzerland) specializing in antibody engineering, oncology, and antibody specificity engineering.

Publications per year

2015–2022

6

Publications

6

Asparagine bioavailability governs metastasis in a model of breast cancer

Simon Knott, Elvin Wagenblast, Showkhin Khan et al. · Nature · 2018 · 554 citations

Medicine, Cancer Biology, Oncology +14

A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis

Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel et al. · Nature · 2015 · 459 citations · Full text

Medicine, Cancer Biology, Oncology +10

Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing

Tobias Killian, Steffen Dickopf, Alexander K. Haas et al. · Scientific Reports · 2017 · 17 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +11

Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies

Steffen Dickopf, Can M. Buldun, Vedran Vasic et al. · Biological Chemistry · 2022 · 15 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +17

Highly flexible, IgG-shaped, trivalent antibodies effectively target tumor cells and induce T cell-mediated killing

Steffen Dickopf, Matthias E. Lauer, Philippe Ringler et al. · Biological Chemistry · 2018 · 13 citations · Full text

Pharmacy, Immunology, Oncology +17

1–5 of 6